Inventor
YONEMORI JINICHI
JP13 patents
⚠️ This page may combine multiple inventors who share the name “YONEMORI JINICHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAKEDA PHARMACEUTICALS CO
12 patentsUS10548899B2Feb 4, 2020
Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activity
TAKEDA PHARMACEUTICALS CO7 citations84
US10428056B2Oct 1, 2019
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO4 citations84
US10323027B2Jun 18, 2019
2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor
TAKEDA PHARMACEUTICALS CO4 citations84
US9878989B2Jan 30, 2018
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO7 citations84
US10899752B2Jan 26, 2021
2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor
TAKEDA PHARMACEUTICALS CO1 citations73
US11236099B2Feb 1, 2022
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO4 citations71
US10548877B2Feb 4, 2020
Aromatic ring compound
TAKEDA PHARMACEUTICALS CO2 citations71
US10435399B2Oct 8, 2019
HDAC6 inhibitory heterocyclic compound
TAKEDA PHARMACEUTICALS CO5 citations71
US12378256B2Aug 5, 2025
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations61
US11952344B2Apr 9, 2024
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO0 citations50
US10131653B2Nov 20, 2018
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations50
US12084436B2Sep 10, 2024
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations49